SCHEMBL2396142

SCHEMBL2396142

Cc1cccc(-c2n[nH]c3cnc4ccc(-c5ccc(-c6ncco6)nc5)cc4c23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 7/20 0.38
▸ MAP3K5 Q99683 2/20 0.37
▸ CLK4 Q9HAZ1 6/20 0.36
▸ MAP4K4 O95819 2/20 0.36
▸ CDK9 P50750 2/20 0.35
▸ CCNT1 O60563 1/20 0.35
▸ CCNA2 P20248 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1558633 0.81 MTOR (0.38) PIM1CLK4ALDH1A1LRRK2CHEK1
SCHEMBL2398692 0.76 CNR2 (0.48) PIM1MAPK1LRRK2KDR
SCHEMBL1559214 0.75 MAPK10 (0.46) CLK4MAP4K4KDM4EMEN1USP2
SCHEMBL1558709 0.74 NPBWR1 (0.46) MAP4K4MEN1ALDH1A1LMNACYP1A2
SCHEMBL2398645 0.74 LRRK2 (0.42) CLK4USP2ALDH1A1CYP1A2CYP3A4
SCHEMBL2396913 0.74 RIPK2 (0.39) PIM1CLK4MAP4K4LRRK2MAP2K4
SCHEMBL1558643 0.73 PIM1 (0.39) PIM1MAP3K5CLK4MAP4K4KDM4E
SCHEMBL1559198 0.72 PDPK1 (0.46) CLK4MAP4K4KDM4EALDH1A1LMNA
SCHEMBL1559133 0.72 MAP3K5 (0.40) PIM1MAP3K5MAP4K4KDM4EMEN1
SCHEMBL1559354 0.71 PIM1 (0.58) PIM1CLK4MAP4K4CDK9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212053-A1 PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS PROGENICS PHARMACEUTICALS, INC. 2011-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212053-A1 PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS PIK3CA, AKT1, PIK3R5 PIM1 417/4885MAP3K5 56/4885CLK4 814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback